Cellares is seeking an innovative and highly motivated Senior Analytical Transfer Scientist with expertise in method transfer, validation and development of bioanalytical methods to support the Cell therapy Analytical Science and Technology team. This individual will interface cross-functionally across the Quality Control, Manufacturing Science and Technology, Quality, Analytical Development team, Regulatory and serve as the analytical subject matter expert (SME) in supporting product development and regulatory submission. This individual will contribute significantly in method transfer activities, validation, method performance, reagent or critical reagent qualification of our advanced cell therapy analytical Cell Q platform.
The primary focus of this position is to design and implement new cell therapy method validation, and to transfer and drive continuous improvement of the Cellares analytical platform. The ideal candidate will be a technical leader and cross-functional collaborator with demonstrated expertise in developing robust autologous and allogeneic cell therapy methods.
Candidates should also enjoy working in a fast-paced, mission-driven environment, and be prepared to tackle a broad selection of challenges as the company grows.
Responsibilities
Lead the method transfer, Validation and optimization (if necessary) of analytical methods for cell and gene therapies, including assays for identity, potency, purity, and safety (e.g., qPCR/ddPCR, flow cytometry, ELISA, cell-based assays, viral vector quantification)
Oversee the transfer of analytical methods to internal or external Quality Control laboratories, ensuring adherence to GMP and regulatory guidelines
Execute advanced testing for product characterization, process development, stability testing, and comparability assessments to align with FDA, EMA, and ICH standards
Analyze complex bioanalytical data and prepare technical reports, protocols, and analytical sections for regulatory submissions, including IND, BLA, and MAA filings
Ensure all analytical methods comply with cGMP, FDA, EMA, and ICH guidelines, providing technical support during regulatory submissions and inquiries
Collaborate closely with Process Development, Manufacturing, Quality Control, and R&D teams to provide analytical support across product development stages
Stay informed about the latest advancements in analytical technologies and evaluate new tools to enhance the team’s capabilities
Requirements
Master's or Ph.D. in Analytical Chemistry, Biochemistry, Molecular Biology, or a related field with 6-14 years of relevant experience in cell and gene therapy
Strong experience with bioanalytical techniques, including qPCR/ddPCR, flow cytometry, ELISA, cell-based potency assays, and viral vector assays (AAV, lentivirus)
Experience in method development, validation, and transfer under GMP conditions for cell and gene therapy products
Knowledge of regulatory filing requirements for viral vectors, gene-modified cells, and advanced therapeutic products
Proficiency in data analysis using software tools like FlowJo, JMP, and GraphPad Prism
Experience working in cross-functional teams in a fast-paced, regulatory-driven environment
Self-awareness, integrity, authenticity, and a growth/entrepreneurial mindset
This is Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.
The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.
Leveling will be based on overall experience, education, and demonstration of knowledge throughout the interview process.
